$2.26T
Total marketcap
$393.06B
Total volume
BTC 55.36%     ETH 9.33%
Dominance

Oncoinvent ASA BRRGF Stock

$97.09   0.000000%
Add to favorites
Market Cap
$434.83M
LOW - HIGH [24H]
$0.00 - $0.00
VOLUME [24H]
$0.00
P/E Ratio
0
Earnings per share
$0.00
ISIN
NO0013251173
Price   Prediction

Oncoinvent ASA Price Chart

Sorry, that's all we've gotfor now...

Oncoinvent ASA BRRGF Financial and Trading Overview

Oncoinvent ASA stock price 97.09 USD
Previous Close 97.09 USD
Open 0.03 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.03 - 0.03 USD
52 Week Range 0.03 - 97.09 USD
Volume 37.31K USD
Avg. Volume 0 USD
Market Cap 434.83M USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

BRRGF Valuation Measures

Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 21.745697
Price/Book (mrq) 13.0296545
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Oncoinvent ASA Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 0%
S&P500 52-Week Change 29.00%
52 Week High 97.09 USD
52 Week Low 0.03 USD
50-Day Moving Average 97.09 USD
200-Day Moving Average 97.09 USD

BRRGF Share Statistics

Avg. Volume (3 month) 0 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 44.78K
Float 656.37K
Short Ratio N/A
% Held by Insiders 26.77%
% Held by Institutions 38.69%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:100

Financial Highlights

Fiscal Year

Fiscal Year Ends N/A
Most Recent Quarter (mrq) N/A
Next Fiscal Year End N/A

Profitability

Profit Margin 0%
Operating Margin (ttm) -434.93%
Gross Margin 100.00%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 20M USD
Revenue Per Share (ttm) 15.68 USD
Quarterly Revenue Growth (yoy) 17750.70%
Gross Profit (ttm) 20M USD
EBITDA -98866000 USD
Net Income Avi to Common (ttm) -106727000 USD
Diluted EPS (ttm) -204.13
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 75.39M USD
Total Cash Per Share (mrq) 77.13 USD
Total Debt (mrq) 6.21M USD
Total Debt/Equity (mrq) 8.95 USD
Current Ratio (mrq) 2.606
Book Value Per Share (mrq) 7.4517713

Cash Flow Statement

Operating Cash Flow (ttm) -83798000 USD
Levered Free Cash Flow (ttm) N/A

Profile of Oncoinvent ASA

Country United States
State N/A
City Oslo
Address Gullhaugveien 7
ZIP 0484
Phone 47 22 18 33 05
Website https://www.oncoinvent.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 36

Oncoinvent ASA, a clinical stage company, develops radiopharmaceutical therapies against cancer. Its lead product candidate is Radspherin, an alpha-radiation therapy candidate for treating cancer that have spread to body cavities, including peritoneum in two phase 1/2a trials and one randomized phase 2 trial. The company is based in Oslo, Norway.

Q&A For Oncoinvent ASA Stock

What is a current BRRGF stock price?

Oncoinvent ASA BRRGF stock price today per share is 97.09 USD.

How to purchase Oncoinvent ASA stock?

You can buy BRRGF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Oncoinvent ASA?

The stock symbol or ticker of Oncoinvent ASA is BRRGF.

Which industry does the Oncoinvent ASA company belong to?

The Oncoinvent ASA industry is Biotechnology.

How many shares does Oncoinvent ASA have in circulation?

The max supply of Oncoinvent ASA shares is 4.48M.

What is Oncoinvent ASA Price to Earnings Ratio (PE Ratio)?

Oncoinvent ASA PE Ratio is 0.00000000 now.

What was Oncoinvent ASA earnings per share over the trailing 12 months (TTM)?

Oncoinvent ASA EPS is 0 USD over the trailing 12 months.

Which sector does the Oncoinvent ASA company belong to?

The Oncoinvent ASA sector is Healthcare.

Select currency